Dehydrodidemnin B as an L-type calcium channel enhancer

Details Dehydrodidemnin B as an L-type calcium channel enhancer Dehydrodidemnin B as an L-type calcium channel enhancer

1998-05-06

2000-02-29

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 11, 530317, A61K 3800, C07K 500, C07K 700, C07K 1600

Patent

active

060309431

ABSTRACT:
This invention relates to a new use discovered for the compound known as Aplidine (dehydrodidemnin B) which has the following structure: Aplidine has been found to be a potent L-type calcium channel enhancer in the human heart. This effect makes Aplidine a very useful drug for the treatment of congestive heart failure, as well as useful for the treatment of atrial fibrillation.

REFERENCES:
patent: 5580871 (1996-12-01), Earl

Affiliated with

Also associated with

Rating

Dehydrodidemnin B as an L-type calcium channel enhancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dehydrodidemnin B as an L-type calcium channel enhancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dehydrodidemnin B as an L-type calcium channel enhancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-683017